Developing new lipids to deliver RNA into cells
Ionizable Triazine Lipids for RNA Delivery
['FUNDING_R15'] · GETTYSBURG COLLEGE · NIH-11124451
This study is exploring new ways to help deliver RNA treatments into cells more effectively, which could lead to better therapies for genetic disorders and other diseases that need gene editing or silencing.
Quick facts
| Phase | ['FUNDING_R15'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GETTYSBURG COLLEGE (nih funded) |
| Locations | 1 site (GETTYSBURG, UNITED STATES) |
| Trial ID | NIH-11124451 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a new library of ionizable triazine lipids that can effectively package RNA into lipid nanoparticles for cellular delivery. RNA therapies have the potential to treat various diseases by silencing genes or editing genetic material, but delivering RNA into cells is challenging due to its size and instability. The researchers aim to enhance the delivery process by studying how different lipid structures interact with RNA and cell membranes, ultimately improving the effectiveness of RNA-based treatments. Patients may benefit from advancements in RNA therapies that could lead to new treatments for genetic disorders and other diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic disorders or conditions that could be treated with RNA therapies.
Not a fit: Patients with conditions that do not involve RNA-based therapies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective RNA-based therapies for a variety of diseases.
How similar studies have performed: Previous research has shown promise in using lipid nanoparticles for RNA delivery, indicating that this approach has potential for success.
Where this research is happening
GETTYSBURG, UNITED STATES
- GETTYSBURG COLLEGE — GETTYSBURG, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FUNK, TIMOTHY WILLIAM — GETTYSBURG COLLEGE
- Study coordinator: FUNK, TIMOTHY WILLIAM
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.